Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 12
Tables & Figures: 287
Countries covered: 18
Pages: 207
Download Free PDF

Neurovascular Embolization Market
Get a free sample of this reportGet a free sample of this report Neurovascular Embolization Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Neurovascular Embolization Market Share
The neurovascular embolization industry is consolidated, with key players such as Medtronic, Stryker, Cerenovus (Johnson & Johnson), and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, Medtronic's pipeline flex embolization device with shield technology has received FDA approval. This technology is a notable advancement in flow diversion therapy, reducing the risk of clot formation on the device's surface and improving treatment safety and efficacy.
Some of the eminent market participants operating in the neurovascular embolization industry include: